Rutgers, The State University of New Jersey
Office of the Vice President for Research
& Graduate & Professional Education
Subscribe, unsubscribe, or send comments to mueller@orsp.rutgers.edu
Life Sciences GrantNet November 2008
The Life Sciences GrantNet is a new information communication tool directed toward faculty interested in research and education programs with a focus on life science and technology. It provides a compendium of notices, program announcements, and requests for application from the U.S. Department of Health and Human Services’ National Institutes of Health, the Agency for Health Quality Research, the U.S. Department of Defense’s Army Medical Research and Material Command, and a number of private foundations providing funding for life science research.
Even faculty who do not necessarily identify their research interests with having potential life science applications are encouraged to review these funding opportunities, as many involve interdisciplinary research involving both behavioral, natural, and computer science and engineering applications.
Visit http://www.grants.gov and http://grants.nih.gov/grants/oer.htm to conduct your own search for life science funding opportunities.
Note: Rutgers' Office of Research and Sponsored Programs (ORSP) internal deadline for completed applications is 5 days prior to the funding agency deadline. Submit proposals on-line using the ORSP Proposal Delivery System (PDS), or contact the Grant Specialist for your department or program.
US Army Medical Research and Materiel Command Broad Agency Announcement (attached file)
Open October 1, 2008, to September 29, 2009
Research proposals are sought from educational institutions, nonprofit organizations, private industry, and domestic and foreign government agencies. This is a continuously open announcement; pre-proposals may be submitted and will be evaluated at any time throughout the year, unless otherwise noted or stated in a separate announcement. Research Areas of Interest: A. Military Infectious Diseases Research Program; B. Combat Casualty Care Research Program; C. Military Operational Medicine Research Program; D. Medical Biological Defense Research Program; E. Medical Chemical Defense Research Program; F. Telemedicine and Advanced Technology Program; G. Special Programs.
DEPARTMENT OF HEALTH AND HUMAN SERVICES (DHHS)
See also The Agency for Healthcare Research and Quality and The National Institutes of Health.
Agency for Healthcare Research and Quality (AHRQ)
Utilizing Health Information Technology (IT) to Improve Health Care Quality (R18)
http://grants.nih.gov/grants/guide/pa-files/PAR-08-270.html
Opening Date: December 26, 2008 (Earliest date an application may be submitted to Grants.gov)
The purpose of this Funding Opportunity Announcement (FOA) is to support health information technology (IT) demonstration projects that evaluate factors associated with successful implementation and utilization of health IT in order to improve the quality, safety, effectiveness and efficiency of health care in ambulatory settings and in the transitions between care settings.
Exploratory and Developmental Grant to Improve Health Care Quality through Health Information Technology (IT) (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-08-269.html
Opening Date: January 16, 2009 (Earliest date an application may be submitted to Grants.gov)
The purpose of this Funding Opportunity Announcement (FOA) is to support short-term preparatory, pilot or feasibility studies that will inform larger scale real world health IT implementation and use or the conduct of more comprehensive health IT implementation research. Research Areas. This FOA is focused on three research areas of interest: Health IT to improve the quality and safety of medication management via the integration and utilization of medication management systems and technologies; Health IT to support patient-centered care, the coordination of care across transitions in care settings, and the use of electronic exchange of health information to improve quality of care; and, Health IT to improve health care decision making through the use of integrated data and knowledge management.
Small Research Grant to Improve Health Care Quality through Health Information Technology (IT) (R03)
http://grants.nih.gov/grants/guide/pa-files/PAR-08-268.html
Opening Date: January 16, 2009 (Earliest date an application may be submitted to Grants.gov)
The purpose of this Funding Opportunity Announcement (FOA) is to support a wide variety of research designs in order to improve the quality, safety, effectiveness, and efficiency of health care through the implementation and use of health IT. These designs include: small pilot and feasibility or self-contained health IT research projects; secondary data analysis of health IT research; and economic (prospective or retrospective) analyses of health IT implementation and use. Through economic analyses estimates of health IT implementation and use costs and benefits will be generated.
National Institutes of Health
Notices
Tissue Microarrays Available for Investigations of Prognostic Breast Cancer Biomarkers (NOT-CA-09-004)
National Cancer Institute
http://grants.nih.gov/grants/guide/notice-files/NOT-CA-09-004.html
Request for Information (RFI): Ongoing Research and Research Needs for Biological Effects of Exposure to Bisphenol A (BPA) (NOT-ES-09-001)
National Institute of Environmental Health Sciences
http://grants.nih.gov/grants/guide/notice-files/NOT-ES-09-001.html
Request for Information: Nomination of Monoclonal Antibody Targets for Epigenetic Research (NOT-RM-09-003)
NIH Roadmap Initiatives
http://grants.nih.gov/grants/guide/notice-files/NOT-RM-09-003.html
Requests for Applications
Medications Development Centers of Excellence (P50)
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-002.html
This FOA issued by the National Institute on Drug Abuse, National Institutes of Health, solicits Center Grant (P50) applications to provide support for research centers (Medications Development Centers of Excellence) dedicated to clinical research directed towards the identification, evaluation and development of safe and effective medications for treatment of substance related disorders (SRDs), alone or with co-morbid conditions. Research may focus on both currently approved and/or novel, investigational medications.
Collaborative Studies on Systems Biology of Complex Phenotypes (R01)
http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-09-007.html
The National Institute of General Medical Sciences (NIGMS) invites applications for collaborative research projects that use systems biology approaches to investigate the mechanisms that underlie genetic determination of complex phenotypes. These projects will combine quantitative modeling approaches and experimental validation of predictive models. It is expected that a team of at least two principal investigators (PIs), one with expertise in systems biology and the other with expertise in the genetics of humans or model organisms, will apply for funding under this FOA.
Roadmap Transformative R01 Program (R01)
http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-08-029.html
LOI December 29; full January 29
As part of the NIH Roadmap for Biomedical Research, the National Institutes of Health invites transformative Research Project Grant (R01) applications from institutions/organizations proposing exceptionally innovative, high risk, original and/or unconventional research with the potential to create new or challenge existing scientific paradigms. Projects must clearly demonstrate potential to produce a major impact in a broad area of biomedical or behavioral research. A major goal of the NIH is to foster bold and creative investigator-initiated research. While R01 grants support the bulk of mainstream NIH investigator-initiated efforts, the Transformative Research Projects Program (T-R01) is designed to provide a more flexible and engaging avenue for support of investigators testing novel concepts and truly transformative ideas.
NIAMS Building Interdisciplinary Research Team (BIRT) Revision Awards (R01)
LOI Jan. 19; full Feb. 19
http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-09-001.html
To promote interdisciplinary research, the NIAMS plans to provide up to 1 year of research revision support (formerly referred to as “competitive supplements”) to active NIAMS R01s (parent grants) to establish collaborations among groups of investigators with expertise in the specific areas listed below. The interdisciplinary collaboration should be basic and/or translational research with high innovation and potentially high impact in the specific NIAMS mission–relevant areas solicited in this FOA. It is understood that such an application may entail high risk. Teams developed under this award are expected to make significant advances beyond the progress expected from the individual researchers alone. Collaborations between scientific areas listed below are selected to pilot the NIAMS BIRT awards and specifically solicited in this FOA. a. Autoimmunity – Gender and sex factors; b. Autoimmunity – Systems biology; c. Developmental biology – Systems biology; d. Regenerative Medicine – Immunology; e. Soft tissue biology – Imaging technologies; f. Tissue engineering – Developmental biology
Superfund Basic Research and Training Program (P42)
http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-08-005.html
LOI March 16; full April 15
The National Institute of Environmental Health Sciences (NIEHS) is announcing the continuation of the Superfund Hazardous Substances Basic Research and Training Program [referred to as the Superfund Basic Research Program (SBRP)]. SBRP grants will support coordinated, multi-project, interdisciplinary research programs to address the mandates legislated under the Superfund Amendments and Reauthorization Act of 1986. These mandates include the development of (1) methods and technologies to detect hazardous substances in the environment; (2) advanced techniques for the detection, assessment, and evaluation of the effect on human health of hazardous substances; (3) methods to assess the risks to human health presented by hazardous substances; and (4) basic biological, chemical, and physical methods to reduce the amount and toxicity of hazardous substances. The objective for the SBRP is to develop a holistic research agenda for the protection of human health. This is accomplished by the establishment of interdisciplinary programs that link and integrate biomedical research with related engineering, hydrogeologic, and ecologic components within the context of unique scientific themes developed by the applicant.
Replication and Fine-Mapping Studies for the Genes Environment and Health Initiative (GEI) (R01)
Application Receipt Date: Dec. 1, 2008
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-09-003.html
The purpose of this FOA is to provide support for replication and fine-mapping studies of genetic regions that are putatively associated with common complex traits, primarily those identified by genome-wide association studies (GWAS). The proposed projects should aim to enhance the identification of causal variants influencing complex diseases. Any phenotype may be appropriate for these projects (i.e., studies need not be oriented on cancer or cancer-related phenotypes).
The Mouse Gene Development Initiative (R01)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): January 27, 2009
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-015.html
This funding opportunity announcement (FOA), requests research grant applications that propose to 1) map traits associated with addiction by varying environmental factors at different states of development across inbred strains of mice including using, but not limited to, selective breeding strategies, recombinant inbred mice, the collaborative cross, and haplotype associative mapping with inbred strains; or 2) Identify epigenetic and genetic modifiers that under different environmental and developmental conditions produces different phenotypic outcomes in mice carrying a defined genetic variant, (e.g., knockout, CNVs).
Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R01)
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): January 28, 2009
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-017.html
The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) and the National Institute of Neurological Disorders and Stroke (NINDS) is to issue a Request for Applications (RFA) to investigate CNS changes that occur with chronic pain, and how these changes parallel those that occur with drug addiction. Of interest will be how chronic pain changes the CNS, how analgesics of various classes impact pain-induced CNS changes, and how analgesics in the absence of pain (some of which have abuse potential) produce CNS changes. The temporal course of these changes will also be of interest. A focus of this research will be comparing and contrasting these CNS changes in an effort to identify shared and unique mechanisms involved in pain, analgesia and drug abuse, as well as environmental and genetic factors that influence these changes.
Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R21)
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): January 28, 2009
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-018.html
Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R03)
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): January 28, 2009
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-019.html
Pediatric Pharmacology and Therapeutics Research Consortium (PPTRC) (U54)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): March 31, 2009
http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-08-021.html
This FOA issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH), solicits grant applications from institutions/organizations for the creation of Pediatric Pharmacology and Therapeutics Research Consortium (PPTRC) Nodal Centers to conduct comprehensive translational/basic and clinical research in pediatric therapeutics. A major goal of the PPTRC Nodal Centers will be to conduct research that will fill gaps in knowledge that may be responsible for failed efficacy trials or that may prevent Food and Drug Administration (FDA) labeling of drugs in pediatrics. In addition, the Consortium will be expected to adopt a new paradigm of promoting personalized pediatric therapeutics and promote a greater understanding of the interrelationship among disease processes, and therapy across the developmental spectrum. Testing of new molecular entities, pediatric formulations, novel therapeutic approaches, new types of delivery systems and development and testing of biomarkers will be priorities for the consortium. Each application will have a translational, a pharmacometric and a clinical research core in addition to an administrative unit. Individual PPTRC Nodal Centers must involve collaborating investigators at two or more different institutions.The Consortium will also be a locus of training future leaders and researchers in pediatric clinical and developmental pharmacology.
Clinical Pharmacotherapy for PTSD: Single and Collaborative Studies (R34)
National Institute of Mental Health
Center for Scientific Review
Application Receipt Date(s): January 14, 2009
http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-09-090.html
The sponsoring agencies jointly issue this Funding Opportunity Announcement (FOA) to stimulate research grant applications focused on pharmacological treatments for Post-Traumatic Stress Disorder (PTSD). Medications along a continuum of development and testing (i.e., exploratory compounds ready for human testing, medications used in other areas of medicine and thought to be useful for a new indication (PTSD), and psychiatric medications currently used off-label to treat PTSD) are appropriate as the focus of a research grant application in response to this FOA. The sponsoring agencies seek to advance PTSD pharmacotherapy research by providing resources to better understand feasibility, tolerability, acceptance, safety, possible efficacy and risk/benefit ratios pertaining to symptoms and symptom severity, side effects, and treatment gains in functioning associated with available and novel medications. The sponsoring agencies anticipate the results of such studies will help identify potential medications suitable for larger scale efficacy, effectiveness and services research studies.
Summer Institute for Training in Biostatistics II (T15)
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-09-009.html
LOI Dec. 5 and full Jan. 6
The National Heart, Lung and Blood Institute (NHLBI) and the National Center for Research Resources (NCRR) invite applications for training grants to develop, conduct, and evaluate summer courses in the basic principles and methods of biostatistics as employed in biomedical research. The courses will introduce advanced undergraduate students and beginning graduate students to the field of biostatistics for the purpose of encouraging them to pursue careers in biostatistics. The courses will cover the fundamental concepts of probability, statistical reasoning and inferential methods motivated, in part, by examples that include data collected in studies of heart, lung, blood, and sleep disorders. The courses will be taught during the summers of 2010, 2011, 2012 with appropriate modifications or refinements following each of the first two summer sessions.
Program Announcements
Biomedical Technology Research Resource (P41)
http://grants.nih.gov/grants/guide/pa-files/PAR-08-259.html
Pre-application for a Biomedical Technology Research Resource (X02)
http://grants.nih.gov/grants/guide/pa-files/PAR-08-260.html
This FOA issued by the National Center for Research Resources (NCRR), National Institutes of Health (NIH), solicits grant applications for national Biomedical Technology Research Resources. These Resources conduct research and development on new technology and new/improved instruments driven by the needs of basic, translational, and clinical researchers. The Resources are charged to make their technologies available, to train members of the research community in the use of the technologies, and to disseminate these technologies and the Resource’s experimental results broadly. Only those with current P41 awards from NCRR or those who have been approved through the X02 pre-application process can submit an application under this FOA.
Aging Research Dissertation Awards to Increase Diversity (R36)
http://grants.nih.gov/grants/guide/pa-files/PAR-08-250.html
The National Institute on Aging (NIA) announces the reissuance of a Funding Opportunity Announcement (FOA) that provides dissertation awards (R36) in all areas of research within NIA’s mandate to increase diversity of the research workforce on research on aging and aging-related health conditions. These awards are available to qualified Predoctoral students in accredited research doctoral programs in the United States (including Puerto Rico and other U.S. territories or possessions). This funding opportunity will use the Dissertation Award R36 grant mechanism. The NIA expects to award $250,000 to $300,000 annually beginning in Fiscal Year 2009 to support up to 5 dissertation awards.
Archiving and Development of Social-behavioral Datasets in Aging Related Studies (R03)
http://grants.nih.gov/grants/guide/pa-files/PA-08-252.html
This Funding Opportunity Announcement (FOA), issued by the National Institute on Aging (NIA) is seeking small grant (R03) applications to stimulate and facilitate data archiving and development related to cognitive psychology, behavioral interventions in the context of randomized controlled trials (RCTs), demography, economics, epidemiology, behavioral genetics and other behavioral research on aging for secondary analysis. -Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Center for Inherited Disease Research (CIDR) High Throughput Genotyping Resource Access (X01)
http://grants.nih.gov/grants/guide/pa-files/PAR-08-258.html
CIDR high-throughput genotyping and supporting statistical genetics services are designed to aid investigations seeking to identify genes that contribute to human health and disease. The services provided through CIDR concentrate primarily on multi-factorial hereditary disease, but other types of projects can also be accommodated. CIDR provides the most up-to-date genotyping platforms and services. This is an NIH-wide initiative that is being managed by NHGRI. Information about the current services offered can be accessed via: http://www.cidr.jhmi.edu.
Metals in Medicine (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-08-251.html
Purpose. The objective of this Funding Opportunity Announcement (FOA), issued by the National Institute of General Medical Sciences (NIGMS), National Cancer Institute (NCI), National Institute of Environmental Health Sciences (NIEHS), and the Office of Dietary Supplements (ODS), National Institutes of Health is to encourage research that bridges the areas of inorganic chemistry and medicine. The mechanisms by which organisms control transition metal ions and the roles of these metals in cellular regulation and signaling in health and disease are of principal interest. The interactions of synthetic inorganic complexes with living systems and their components are an additional area of interest. These areas are linked by the need to involve researchers having a deep understanding of inorganic chemistry in medically relevant research. Much of the work is expected to involve collaborations including chemists, biologists, and medical researchers. The results will be relevant to understanding the mechanisms of metal handling by biological systems and the basic cellular roles underlying the nutritional requirement for essential metals. It is expected that this research will also contribute to the identification of new targets for drug discovery, diagnostics, and future therapeutic approaches involving metal complexes, although drug development, per se, is not a focus of the program.
Research to Advance Vaccine Safety (R01 & R21)
http://grants.nih.gov/grants/guide/pa-files/PA-08-256.html
This FOA, entitled Research to Advance Vaccine Safety, is issued by the National Institutes of Health and encourages Research Project Grant (R01) applications from institutions/organizations that propose to support research that will contribute to the overall understanding of vaccine safety. This R01 research opportunity invites studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, or 4) the application of genomic/molecular technologies to improve knowledge of vaccine safety.
Basic and Preclinical Research on Complementary and Alternative Medicine (CAM) (R01)
National Center for Complementary and Alternative Medicine
National Cancer Institute
Office of Dietary Supplements
Application Receipt/Submission Date(s): Multiple dates, see announcement.
http://grants.nih.gov/grants/guide/pa-files/PA-09-010.html
This Funding Opportunity Announcement (FOA) issued by the National Center for Complementary and Alternative Medicine (NCCAM), the National Cancer Institute (NCI), and the Office of Dietary Supplements (ODS), National Institutes of Health (NIH), encourages complementary and alternative medicine (CAM) and conventional researchers to carry out basic and/or preclinical research on CAM areas of special interest with an aim to understand the mechanisms of action of a CAM modality.
Contextual Approaches to Prevention of Unintended Pregnancy (R01)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Date(s): Multiple dates, see announcement.
http://grants.nih.gov/grants/guide/pa-files/PA-09-014.html
The purpose of this Funding Opportunity Announcement (FOA) is to strengthen and revitalize scientific research on the prevention of unintended pregnancies in the United States. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites R01 research grant applications that will inform interventions addressing the cultural and structural factors that produce high rates of unintended pregnancy across the reproductive age span, especially in low-income populations in the United States. These interventions can operate at a wide range of levels, from clinical interventions to interventions that influence cultural, economic, social, structural, and/or policy factors contributing to unintended pregnancy.
Contextual Approaches to Prevention of Unintended Pregnancy (R21)
(PA-09-015)
Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)
National Institute on Drug Abuse
Application Receipt/Submission Date(s): December 15, 2008, July 15, 2009, December 15, 2009, July 15, 2010, December 15, 2010, July 15, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-011.html
This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes on Health, encourages Research Project Grant (R24) applications from institutions that historically and/or currently serve students from diverse and disadvantaged backgrounds that aim to increase their capacity to conduct drug abuse and addiction research. The applications should propose to foster the research career development of a diverse cadre of faculty, students and staff who are currently underrepresented in drug abuse research, and to enhance research infrastructure at the institution.
Pre-Application for the 2009 NIH Director’s Pioneer Award Program (X02)
NIH Roadmap Initiatives
Application Receipt/Submission Date(s): December 17, 2008
http://grants.nih.gov/grants/guide/pa-files/PAR-09-012.html
The NIH Director’s Pioneer Award Program complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists of exceptional creativity who propose pioneering and possibly transformative approaches to addressing major biomedical or behavioral challenges. To be considered pioneering, the proposed research must reflect ideas substantially different from those already being pursued in the investigator’s laboratory or elsewhere. The NIH Director’s Pioneer Award Program is a High-Risk Research initiative of the NIH Roadmap for Medical Research.
Pre-Application for the 2009 NIH Director’s New Innovator Award Program (X02)
NIH Roadmap Initiatives
Application Receipt/Submission Date(s): January 15, 2009
http://grants.nih.gov/grants/guide/pa-files/PAR-09-013.html
The NIH Director’s New Innovator Awards Program (http://nihroadmap.nih.gov/newinnovator/) was created in 2007 to support a small number of new investigators of exceptional creativity who propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems in biomedical and behavioral research. The research proposed need not be in a conventional biomedical or behavioral discipline but must be relevant to the mission of NIH. The New Innovator Awards complement ongoing efforts by NIH and its Institutes and Centers to fund new investigators through R01 grants, which continue to be the major source of NIH support for new investigators. The purpose of this FOA is to solicit pre-applications for the NIH Director’s New Innovator Award. Pre-applications are a necessary first step in applying for a 2009 New Innovator Award. Pre-applications will be evaluated by a group of external reviewers. Those investigators whose submissions are judged to be the most outstanding will be notified of the opportunity to submit full (DP2) applications under RFA-RM-09-003. All awards will be made under RFA-RM-09-003. No awards will be made under this announcement. For additional information, consult the FAQs at
FOUNDATION FUNDING OPPORTUNITIES
Goldhirsh Foundation Brain Tumor Research Awards Program
$600,000 3-Year and $100,000 1-Year USD Grants
Deadline for Initial Application: January 13, 2009
http://www.goldhirshfoundation.org/
The Goldhirsh Foundation provides strategic investment in brain tumor research to accelerate progress toward more effective treatment for malignant diffuse glioma tumors. Applications are encouraged from investigators working in the continuum between basic research and clinical application, integrating and translating knowledge in various disciplines into meaningful progress for patients. Examples of funding areas include but are not limited to oncogenomics and proteomics, genetically engineered models, the discovery and testing of small molecule therapies, unusual drug delivery systems, or improved brain imaging techniques. Research projects at the interface of developmental biology and cancer along the stem cell to glial axis are eligible.
Klarman Family Foundation Grants Program in Eating Disorders Research
http://www.tmfnet.org/grantmake.html#klarman
Deadline: Nov. 20, 2008
The Program's goal is to expand the number of outstanding scientists whose research explores the basic biology of anorexia nervosa, bulimia nervosa and/or binge eating disorder. The long term goal is to accelerate progress in developing effective treatments for these disorders.
SERCEB Career Development for Basic Scientists in Emerging Infections and Biodefense
http://www.serceb.org/modules/serceb_requests/index.php?id=2
Applications accepted and reviewed on a rolling basis.
SERCEB offers a career development program in basic science research in emerging infections and biodefense to provide an in-depth, mentored experience of the highest quality for selected highly motivated and talented persons who are beyond the post-doctoral phase of their careers and wish to pursue such training. Successful applicants will be placed in premier biodefense basic research laboratories for a 6-12 month period to conduct science related to diagnostics, vaccines or new drugs against category A and other select agents and emerging infections. This work will be enhanced by opportunities for additional courses in bioscience and biodefense, an opportunity to participate in training experiences in BSL3-4 facilities and select agent science, and attendance at annual scientific meetings of SERCEB.
The Leukemia Research Foundation New Investigator Grants
http://216.235.201.220/NETCOMMUNITY/Page.aspx?pid=216&srcid=215
Deadline: February 13, 2009.
Funding for projects up to $100,000. The grant period is one year. Funding cycle begins July 1, 2009.
McKnight Endowment Fund for Neuroscience McKnight Scholar Awards
http://www.mcknight.org/neuroscience/awards/scholar.aspx
Deadline: January 2, 2009
The awards support young scientists who hold the M.D. and/or Ph.D. degree, who have completed formal postdoctoral training, and who demonstrate a commitment to neuroscience. The Endowment Fund especially seeks applicants working on problems that, if solved at the basic level, would have immediate and significant impact on clinically relevant issues.
McKnight Technological Innovations in Neuroscience Awards
http://www.mcknight.org/neuroscience/awards/technology.aspx
Deadline: December 1, 2008
These awards support scientists working on new and unusual approaches to understanding brain function. The program seeks to advance and enlarge the range of technologies available to the neurosciences. It does not support research based primarily on existing techniques. The Endowment Fund is especially interested in how technology may be used or adapted to monitor, manipulate, analyze, or model brain function at any level, from the molecular to the entire organism. Collaborative and cross-disciplinary applications are invited.